compliance risks for clinical laboratories sandra van der vaart, esq. sixth annual national congress...
TRANSCRIPT
![Page 1: Compliance Risks for Clinical Laboratories Sandra van der Vaart, Esq. Sixth Annual National Congress on Health Care Compliance February 7, 2003](https://reader035.vdocuments.us/reader035/viewer/2022072013/56649e4e5503460f94b45a3c/html5/thumbnails/1.jpg)
Compliance Risks for Clinical LaboratoriesSandra van der Vaart, Esq.
Sixth Annual National Congress
on Health Care ComplianceFebruary 7, 2003
![Page 2: Compliance Risks for Clinical Laboratories Sandra van der Vaart, Esq. Sixth Annual National Congress on Health Care Compliance February 7, 2003](https://reader035.vdocuments.us/reader035/viewer/2022072013/56649e4e5503460f94b45a3c/html5/thumbnails/2.jpg)
2/7/2003 2
On Corporate Integrity
“By complying with all applicable laws and regulations, and by adhering to LabCorp’s standards of business conduct, we earn the trust and respect of our fellow workers, customers, shareholders, government employees, elected officials, suppliers, neighbors, friends, the media, and the general public. Therefore, I believe that a strong commitment to corporate integrity is the key to our future success.”
Thomas P. Mac Mahon, President and Chairman of the Board
Laboratory Corporation of America
![Page 3: Compliance Risks for Clinical Laboratories Sandra van der Vaart, Esq. Sixth Annual National Congress on Health Care Compliance February 7, 2003](https://reader035.vdocuments.us/reader035/viewer/2022072013/56649e4e5503460f94b45a3c/html5/thumbnails/3.jpg)
2/7/2003 3
OIG Model Compliance Program Guidance for Clinical Laboratories
Medical Necessity– Requisition Design– Notices to Physicians– Test Utilization Monitoring
![Page 4: Compliance Risks for Clinical Laboratories Sandra van der Vaart, Esq. Sixth Annual National Congress on Health Care Compliance February 7, 2003](https://reader035.vdocuments.us/reader035/viewer/2022072013/56649e4e5503460f94b45a3c/html5/thumbnails/4.jpg)
2/7/2003 4
OIG Model Compliance Program for Clinical Laboratories (cont.)
Billing– CPT/HCPCS Codes– ICD-9 Diagnostic Codes– Tests Covered by Claims for Reimbursement– Billing of Automated Multichannel Chemistry tests– Billing of Calculations
![Page 5: Compliance Risks for Clinical Laboratories Sandra van der Vaart, Esq. Sixth Annual National Congress on Health Care Compliance February 7, 2003](https://reader035.vdocuments.us/reader035/viewer/2022072013/56649e4e5503460f94b45a3c/html5/thumbnails/5.jpg)
2/7/2003 5
OIG Model Compliance Program for Clinical Laboratories (cont.)
Standing Orders
Marketing
Physician Profile Pricing
![Page 6: Compliance Risks for Clinical Laboratories Sandra van der Vaart, Esq. Sixth Annual National Congress on Health Care Compliance February 7, 2003](https://reader035.vdocuments.us/reader035/viewer/2022072013/56649e4e5503460f94b45a3c/html5/thumbnails/6.jpg)
2/7/2003 6
Fraud Alerts
In-office Phlebotomy
Waivers of Co-pays, Coinsurance, and Deductibles
Professional Courtesy
Rental or Lease of Space from Physicians
![Page 7: Compliance Risks for Clinical Laboratories Sandra van der Vaart, Esq. Sixth Annual National Congress on Health Care Compliance February 7, 2003](https://reader035.vdocuments.us/reader035/viewer/2022072013/56649e4e5503460f94b45a3c/html5/thumbnails/7.jpg)
2/7/2003 7
Standard ABN
The Advance Beneficiary Notice (“ABN”) informs Medicare patients that their tests may not be covered by Medicare and that they may be liable for any charges for the test.
Valid ABN’s must contain:– Patient’s name – Reasons why the test might not be covered– A checked box indicating the patient’s intent– Patient’s signature and date
![Page 8: Compliance Risks for Clinical Laboratories Sandra van der Vaart, Esq. Sixth Annual National Congress on Health Care Compliance February 7, 2003](https://reader035.vdocuments.us/reader035/viewer/2022072013/56649e4e5503460f94b45a3c/html5/thumbnails/8.jpg)
2/7/2003 8
2003 OIG Work Plan
Laboratory Proficiency Testing
Clinical Laboratory Testing Outside Certified Specialties
Part B Claims for Glucose Testing
![Page 9: Compliance Risks for Clinical Laboratories Sandra van der Vaart, Esq. Sixth Annual National Congress on Health Care Compliance February 7, 2003](https://reader035.vdocuments.us/reader035/viewer/2022072013/56649e4e5503460f94b45a3c/html5/thumbnails/9.jpg)
2/7/2003 9
HIPAA Compliance
Privacy– Use of Protected Health Care Information (“PHI”)– Provider Responsibility
Security– Access to Facilities– Access to Information
![Page 10: Compliance Risks for Clinical Laboratories Sandra van der Vaart, Esq. Sixth Annual National Congress on Health Care Compliance February 7, 2003](https://reader035.vdocuments.us/reader035/viewer/2022072013/56649e4e5503460f94b45a3c/html5/thumbnails/10.jpg)